scispace - formally typeset
S

Stephen V. Faraone

Researcher at State University of New York Upstate Medical University

Publications -  1470
Citations -  155368

Stephen V. Faraone is an academic researcher from State University of New York Upstate Medical University. The author has contributed to research in topics: Attention deficit hyperactivity disorder & Bipolar disorder. The author has an hindex of 188, co-authored 1427 publications receiving 140298 citations. Previous affiliations of Stephen V. Faraone include University of Bergen & National Institute for Health Research.

Papers
More filters
Journal ArticleDOI

Familial risk analyses of attention deficit hyperactivity disorder and substance use disorders.

TL;DR: In this paper, first-degree relatives from a large group of pediatrically and psychiatrically referred boys with and without ADHD were comprehensively assessed by blind raters with structured diagnostic interviews.
Journal ArticleDOI

Substance use disorders in adolescents with attention deficit hyperactivity disorder: a 4‐year follow‐up study

TL;DR: A childhood diagnosis of attention deficit hyperactivity disorder is a risk factor for psychoactive substance use disorder and nicotine dependence in adolescence and comorbid conduct disorder, but not oppositional defiant disorder, further increases the risk of developing psychoactive substances use disorder or nicotine dependence.
Journal ArticleDOI

How cardinal are cardinal symptoms in pediatric bipolar disorder? An examination of clinical correlates.

TL;DR: These findings support the clinical relevance of severe irritability as the most common presentation of mania in the young and support the use of unmodified DSM-IV criteria in establishing the diagnosis ofMania in pediatric populations.
Journal ArticleDOI

Systematic chart review of the pharmacologic treatment of comorbid attention deficit hyperactivity disorder in youth with bipolar disorder.

TL;DR: Although tricyclic antidepressants (TCAs) significantly increased the probability of ADHD improvement following mood stabilization, there was also a significant association between treatment with TCAs and relapse of manic symptoms.